Controlled release of nerve growth factor enhances sciatic nerve regeneration

Area of Science:

• Biomaterials Science
• Neuroscience
• Regenerative Medicine

Background:

• Peripheral nerve injuries often result in significant functional deficits.
• Growth factors, particularly nerve growth factor (NGF), show promise for enhancing nerve regeneration.
• Controlled delivery systems are needed to optimize growth factor efficacy and duration.

Purpose of the Study:

• To develop and evaluate a novel heparin-based delivery system for sustained nerve growth factor (NGF) release.
• To assess the efficacy of this system in promoting peripheral nerve regeneration across a rat sciatic nerve defect.
• To determine the dose-dependent effect of NGF delivered via this system on axonal regeneration.

Main Methods:

• Development of a fibrin matrix incorporating heparin to immobilize and control NGF diffusion.
• Implantation of the delivery system with varying NGF doses (5, 20, 50 ng/mL) into a 13-mm rat sciatic nerve gap.
• Comparison with controls: isografts, fibrin alone, NGF alone, and empty conduits.
• Histomorphometric analysis of nerve regeneration at 6 weeks post-operation.

Main Results:

• The novel delivery system demonstrated a dose-dependent enhancement of axonal regeneration.
• NGF doses of 20 and 50 ng/mL showed no statistical difference in nerve fiber count compared to isografts (positive control).
• Significant improvement in nerve regeneration was observed at both mid-conduit and distal nerve levels.

Conclusions:

• The developed heparin-based delivery system effectively provides sustained release of NGF.
• This controlled NGF delivery significantly enhances peripheral nerve regeneration across short nerve gaps.
• The system represents a promising strategy for improving outcomes in peripheral nerve repair.